Vertex Pharmaceuticals VRTX announced positive data from an interim analysis of the ongoing phase III RAINER study, which evaluated its investigational drug povetacicept for IgA nephropathy (IgAN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results